» Articles » PMID: 19036167

The Future Impact of Population Growth and Aging on Coronary Heart Disease in China: Projections from the Coronary Heart Disease Policy Model-China

Overview
Publisher Biomed Central
Specialty Public Health
Date 2008 Nov 28
PMID 19036167
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Background: China will experience an overall growth and aging of its adult population in coming decades. We used a computer model to forecast the future impact of these demographic changes on coronary heart disease (CHD) in China.

Methods: The CHD Policy Model is a validated state-transition, computer simulation of CHD on a national scale. China-specific CHD risk factor, incidence, case-fatality, and prevalence data were incorporated, and a CHD prediction model was generated from a Chinese cohort study and calibrated to age-specific Chinese mortality rates. Disability-adjusted life years (DALYs) due to CHD were calculated using standard methods. The projected population of China aged 35-84 years was entered, and CHD events, deaths, and DALYs were simulated over 2000-2029. CHD risk factors other than age and case-fatality were held at year 2000 levels. Sensitivity analyses tested uncertainty regarding CHD mortality coding, the proportion of total deaths attributable to CHD, and case-fatality.

Results: We predicted 7.8 million excess CHD events (a 69% increase) and 3.4 million excess CHD deaths (a 64% increase) in the decade 2020-2029 compared with 2000-2009. For 2030, we predicted 71% of almost one million annual CHD deaths will occur in persons >or=65 years old, while 67% of the growing annual burden of CHD death and disability will weigh on adults <65 years old. Substituting alternate CHD mortality assumptions led to 17-20% more predicted CHD deaths over 2000-2029, though the pattern of increases in CHD events and deaths over time remained.

Conclusion: We forecast that absolute numbers of CHD events and deaths will increase dramatically in China over 2010-2029, due to a growing and aging population alone. Recent data suggest CHD risk factor levels are increasing, so our projections may underestimate the extent of the potential CHD epidemic in China.

Citing Articles

Dietary Patterns Associated With Heat Retention in Blood Vessel Syndrome (HRBVS) in Coronary Heart Disease: A Cross-Sectional Study.

Zhang J, Tong H, Jiang L, Hu J Int J Gen Med. 2025; 18:1283-1294.

PMID: 40062358 PMC: 11890399. DOI: 10.2147/IJGM.S510507.


Temporal trends of presumed cardiac origin out-of-hospital cardiac arrest incidence in Guangzhou, southern China: A 10-year consecutive analysis.

Yang T, Wen C, Zhang Y, Xu Y, Liu J, Li Z Resusc Plus. 2025; 22:100883.

PMID: 40008322 PMC: 11850736. DOI: 10.1016/j.resplu.2025.100883.


Epidemiological characteristics, diagnosis and treatment effect of rifampicin-resistant pulmonary tuberculosis (RR-PTB) in Guizhou Province.

Zhou J, Li J, Hu Y, Li S BMC Infect Dis. 2024; 24(1):1058.

PMID: 39333894 PMC: 11429120. DOI: 10.1186/s12879-024-09976-9.


Impact of Smoking Reduction Scenarios on the Burden of Myocardial Infarction in the French Population Until 2035.

Kuhn J, Olie V, Grave C, Le Strat Y, Bonaldi C, Joly P Clin Epidemiol. 2024; 16:605-616.

PMID: 39262929 PMC: 11389704. DOI: 10.2147/CLEP.S440815.


Long-term inhaling ultrafine zinc particles increases cardiac wall stresses elevated by myocardial infarction.

Wang S, Wang H, Li L, Niu P, Yin Z, Huo Y Biomed Eng Online. 2024; 23(1):78.

PMID: 39103913 PMC: 11299344. DOI: 10.1186/s12938-024-01275-3.


References
1.
Yusuf S, Reddy S, Ounpuu S, Anand S . Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001; 104(22):2746-53. DOI: 10.1161/hc4601.099487. View

2.
Wang H, Du S, Zhai F, Popkin B . Trends in the distribution of body mass index among Chinese adults, aged 20-45 years (1989-2000). Int J Obes (Lond). 2006; 31(2):272-8. DOI: 10.1038/sj.ijo.0803416. View

3.
Gaspoz J, Coxson P, Goldman P, Williams L, M Kuntz K, Hunink M . Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease. N Engl J Med. 2002; 346(23):1800-6. DOI: 10.1056/NEJM200206063462309. View

4.
Wu Z, Yao C, Zhao D, Wu G, Wang W, Liu J . Cardiovascular disease risk factor levels and their relations to CVD rates in China--results of Sino-MONICA project. Eur J Cardiovasc Prev Rehabil. 2004; 11(4):275-83. DOI: 10.1097/01.hjr.0000136566.89429.63. View

5.
Goldman L, Coxson P, Hunink M, Goldman P, Tosteson A, Mittleman M . The relative influence of secondary versus primary prevention using the National Cholesterol Education Program Adult Treatment Panel II guidelines. J Am Coll Cardiol. 1999; 34(3):768-76. DOI: 10.1016/s0735-1097(99)00260-0. View